MCK
McKesson Corporation · NYSE
- Sector Distribution Services
- Industry Medical Distributors
- Website mckesson.com
- Employees(FY) 45000
- ISIN US58155Q1031
Performance
-5.34%
1W
-5.79%
1M
+13.62%
3M
-1.79%
6M
+25.71%
YTD
+25.94%
1Y
Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Technical Analysis of MCK 2024-12-12
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-13 02:15
- 2024-12-12 17:50
- 2024-12-12 09:40
- 2024-12-12 08:45
- 2024-12-11 09:00
- 2024-12-06 02:46
Jim Cramer Says McKesson Corporation (MCK) Is A Trump Stock(Yahoo Finance)
- 2024-12-04 08:24
Here’s Why McKesson Corporation (MCK) was Down 15.2% in Q3(Insider Monkey)
- 2024-11-29 07:00
- 2024-11-27 09:50
- 2024-11-27 09:00
- 2024-11-26 09:40
- 2024-11-21 13:05
- 2024-11-21 11:28
- 2024-11-21 09:00
- 2024-11-19 13:39
- 2024-11-19 06:23
- 2024-11-18 07:29
Weekly Stock List(Argus Research)
- 2024-11-14 05:33
Investors Can Find Comfort In McKesson's (NYSE:MCK) Earnings Quality(Simply Wall St.)
- 2024-11-13 18:27
McKesson Stock Gets A RS Rating Lift To 75(Investor's Business Daily)
- 2024-11-13 13:42
- 2024-11-13 12:00
- 2024-11-13 11:56
- 2024-11-13 09:40
- 2024-11-13 09:30
- 2024-11-13 09:28
- 2024-11-13 09:00
- 2024-11-12 14:12
Argus Adjusts Price Target on McKesson to $660 From $570(MT Newswires)
- 2024-11-12 13:27
Analyst Report: Mckesson Corporation(Argus Research)
- 2024-11-12 13:12
Market Update: CB, CMG, MCK, MRK, VSH(Argus Research)
- 2024-11-12 05:10
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.